Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.3440
+0.0290 (9.21%)
At close: Sep 24, 2026
Aptahem AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
8.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 275.79M |
| ExpreS2ion Biotech Holding AB | 24.25M |
| Fluicell AB | 18.44M |
| AcouSort AB | 9.31M |
| OncoZenge AB | 5.97M |
| Biosergen AB | 2.09M |
| NanoEcho AB | 974.00K |
| Alligator Bioscience AB | 681.00K |
Aptahem AB News
- 4 weeks ago - Aptahem AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Aptahem AB Quarterly report: Q1 2026 - Filings
- 7 months ago - Aptahem AB Annual report: Q4 2025 - Filings
- 7 months ago - Aptahem AB Quarterly report: Q4 2025 - Filings
- 10 months ago - Aptahem AB Quarterly report: Q3 2025 - Filings
- 11 months ago - Aptahem AB Transcript: Status Update - Transcripts
- 11 months ago - Aptahem AB Press release: Status Update - Filings